Clofarabine Plus Low-Dose Cytarabine Is as Effective as and Less Toxic Than Intensive Chemotherapy in Elderly AML Patients.

MLA

Takahashi, Koichi, et al. “Clofarabine Plus Low-Dose Cytarabine Is as Effective as and Less Toxic Than Intensive Chemotherapy in Elderly AML Patients.” Clinical Lymphoma, Myeloma & Leukemia, vol. 16, no. 3, Mar. 2016, p. 163. EBSCOhost, https://doi.org/10.1016/j.clml.2015.11.016.

APA

Takahashi, K., Kantarjian, H., Garcia-Manero, G., Borthakur, G., Kadia, T., DiNardo, C., Jabbour, E., Pierce, S., Estrov, Z., Konopleva, M., Andreeff, M., Ravandi, F., & Cortes, J. (2016). Clofarabine Plus Low-Dose Cytarabine Is as Effective as and Less Toxic Than Intensive Chemotherapy in Elderly AML Patients. Clinical Lymphoma, Myeloma & Leukemia, 16(3), 163. https://doi.org/10.1016/j.clml.2015.11.016

Chicago

Takahashi, Koichi, Hagop Kantarjian, Guillermo Garcia-Manero, Gautam Borthakur, Tapan Kadia, Courtney DiNardo, Elias Jabbour, et al. 2016. “Clofarabine Plus Low-Dose Cytarabine Is as Effective as and Less Toxic Than Intensive Chemotherapy in Elderly AML Patients.” Clinical Lymphoma, Myeloma & Leukemia 16 (3): 163. doi:10.1016/j.clml.2015.11.016.